We are going there. See, CTSO is a company who is operating in a top niche market and with a tremendous potential. Sure, the potential needs to be materialized. We are going there. See the increasing acceptance here in Europe, to name Germany, Switzerland and Austria (not to mention the countries given to Fresenius) and also Asia. Look, in Asia, they are much less concerned about the US approval. The success in Europe is a trigger for India and the soon coming market, China and Japan.
I see, that the missing investors guidance needs to be improved, especially in the context of time. In the medical industry, the sales cycle and consequently the repeating businss is much longer than in any other industry. That is something not seen by the people sellling the stocks at around 7 USD. I guess that Chan knows that the acceptance process is very challenging. As we notice however, the past couple of monhts tells us a fast growing accepance. The aim is to become the filter a standard product. All the positive statement from doctors around the globe reinforce the strong and steady move to materialize the unique selling position.
I'm not concerned that the market, at least the weak and shaky hands, doesn't see it yet. The overall picture matters, and that is excellent. Not to mention the other huge market, cancer prevention/fight (mentioned by Chan in his statement of last friday)
where the filter could become a standard product too.
The challenge is at this stage of time, to be patient. The savvy investors are..
